 | • レポートコード：MRC23Q36895 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（2-3日） • 産業分類：医薬品 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の軟骨保護剤市場について調査・分析し、世界の軟骨保護剤市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（ヒアルロン酸Na、グルコサミン硫酸塩、コンドロイチン硫酸塩）、用途別セグメント分析（病院、外来手術センター）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、SANXIN、WanTuMing Biological、TSI Group、Yantai Dongcheng、Focus Chem、YBCC、Runxin Biotechnology、ISBA、Huiwen、QJBCHINA、Meitek (Synutra International)、Hengjie Bio-Pharmaceuticals、Nippon Zoki、GGI、Summit Nutritionals、Sioux Pharm、Ruikangda Biochemical、Guanglong Biochem、Pacific Rainbowなどが含まれています。世界の軟骨保護剤市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、軟骨保護剤市場規模を推定する際に考慮しました。本レポートは、軟骨保護剤の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、軟骨保護剤に関するビジネス上の意思決定に役立てることを目的としています。 ・軟骨保護剤市場の概要 - 製品の定義 - 軟骨保護剤のタイプ別セグメント - 世界の軟骨保護剤市場規模：タイプ別分析（ヒアルロン酸Na、グルコサミン硫酸塩、コンドロイチン硫酸塩） - 軟骨保護剤の用途別セグメント - 世界の軟骨保護剤市場規模：用途別分析（病院、外来手術センター） - 世界の軟骨保護剤市場規模予測（2018年-2029年） - 軟骨保護剤の平均価格推移（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - 軟骨保護剤市場の競争状況およびトレンド ・軟骨保護剤の地域別市場規模 - 北米の軟骨保護剤市場規模（2018年-2029年） - アメリカの軟骨保護剤市場規模（2018年-2029年） - ヨーロッパの軟骨保護剤市場規模（2018年-2029年） - アジア太平洋の軟骨保護剤市場規模（2018年-2029年） - 中国の軟骨保護剤市場規模（2018年-2029年） - 日本の軟骨保護剤市場規模（2018年-2029年） - 韓国の軟骨保護剤市場規模（2018年-2029年） - インドの軟骨保護剤市場規模（2018年-2029年） - オーストラリアの軟骨保護剤市場規模（2018年-2029年） - 中南米の軟骨保護剤市場規模（2018年-2029年） - 中東・アフリカの軟骨保護剤市場規模（2018年-2029年） ・タイプ別セグメント：ヒアルロン酸Na、グルコサミン硫酸塩、コンドロイチン硫酸塩 - 世界の軟骨保護剤のタイプ別販売量（2018年-2023年） - 世界の軟骨保護剤のタイプ別売上（2018年-2023年） - 世界の軟骨保護剤のタイプ別価格 ・用途別セグメント：病院、外来手術センター - 世界の軟骨保護剤の用途別販売量（2018年-2023年） - 世界の軟骨保護剤の用途別売上（2018年-2023年） - 世界の軟骨保護剤の用途別価格 ・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向 SANXIN、WanTuMing Biological、TSI Group、Yantai Dongcheng、Focus Chem、YBCC、Runxin Biotechnology、ISBA、Huiwen、QJBCHINA、Meitek (Synutra International)、Hengjie Bio-Pharmaceuticals、Nippon Zoki、GGI、Summit Nutritionals、Sioux Pharm、Ruikangda Biochemical、Guanglong Biochem、Pacific Rainbow ・産業チェーンと販売チャネルの分析 - 軟骨保護剤産業チェーン分析 - 軟骨保護剤の主要原材料 - 軟骨保護剤の販売チャネル - 軟骨保護剤のディストリビューター - 軟骨保護剤の主要顧客 ・軟骨保護剤市場ダイナミクス - 軟骨保護剤の業界動向 - 軟骨保護剤市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
Highlights
The global Chondroprotective Agent market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Chondroprotective Agent is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Chondroprotective Agent is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Chondroprotective Agent include SANXIN, WanTuMing Biological, TSI Group, Yantai Dongcheng, Focus Chem, YBCC, Runxin Biotechnology, ISBA and Huiwen, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Chondroprotective Agent, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chondroprotective Agent.
The Chondroprotective Agent market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Chondroprotective Agent market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chondroprotective Agent manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
SANXIN
WanTuMing Biological
TSI Group
Yantai Dongcheng
Focus Chem
YBCC
Runxin Biotechnology
ISBA
Huiwen
QJBCHINA
Meitek (Synutra International)
Hengjie Bio-Pharmaceuticals
Nippon Zoki
GGI
Summit Nutritionals
Sioux Pharm
Ruikangda Biochemical
Guanglong Biochem
Pacific Rainbow
Segment by Type
Sodium Hyaluronate
Glucosamine Sulfate
Chondroitin Sulfate
Segment by Application
Hospital
Ambulatory Surgery Center
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Chondroprotective Agent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Chondroprotective Agent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Chondroprotective Agent Market Overview
1.1 Product Overview and Scope of Chondroprotective Agent
1.2 Chondroprotective Agent Segment by Type
1.2.1 Global Chondroprotective Agent Market Value Comparison by Type (2023-2029)
1.2.2 Sodium Hyaluronate
1.2.3 Glucosamine Sulfate
1.2.4 Chondroitin Sulfate
1.3 Chondroprotective Agent Segment by Application
1.3.1 Global Chondroprotective Agent Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Ambulatory Surgery Center
1.4 Global Chondroprotective Agent Market Size Estimates and Forecasts
1.4.1 Global Chondroprotective Agent Revenue 2018-2029
1.4.2 Global Chondroprotective Agent Sales 2018-2029
1.4.3 Global Chondroprotective Agent Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Chondroprotective Agent Market Competition by Manufacturers
2.1 Global Chondroprotective Agent Sales Market Share by Manufacturers (2018-2023)
2.2 Global Chondroprotective Agent Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Chondroprotective Agent Average Price by Manufacturers (2018-2023)
2.4 Global Chondroprotective Agent Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Chondroprotective Agent, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Chondroprotective Agent, Product Type & Application
2.7 Chondroprotective Agent Market Competitive Situation and Trends
2.7.1 Chondroprotective Agent Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Chondroprotective Agent Players Market Share by Revenue
2.7.3 Global Chondroprotective Agent Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Chondroprotective Agent Retrospective Market Scenario by Region
3.1 Global Chondroprotective Agent Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Chondroprotective Agent Global Chondroprotective Agent Sales by Region: 2018-2029
3.2.1 Global Chondroprotective Agent Sales by Region: 2018-2023
3.2.2 Global Chondroprotective Agent Sales by Region: 2024-2029
3.3 Global Chondroprotective Agent Global Chondroprotective Agent Revenue by Region: 2018-2029
3.3.1 Global Chondroprotective Agent Revenue by Region: 2018-2023
3.3.2 Global Chondroprotective Agent Revenue by Region: 2024-2029
3.4 North America Chondroprotective Agent Market Facts & Figures by Country
3.4.1 North America Chondroprotective Agent Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Chondroprotective Agent Sales by Country (2018-2029)
3.4.3 North America Chondroprotective Agent Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Chondroprotective Agent Market Facts & Figures by Country
3.5.1 Europe Chondroprotective Agent Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Chondroprotective Agent Sales by Country (2018-2029)
3.5.3 Europe Chondroprotective Agent Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Chondroprotective Agent Market Facts & Figures by Country
3.6.1 Asia Pacific Chondroprotective Agent Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Chondroprotective Agent Sales by Country (2018-2029)
3.6.3 Asia Pacific Chondroprotective Agent Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Chondroprotective Agent Market Facts & Figures by Country
3.7.1 Latin America Chondroprotective Agent Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Chondroprotective Agent Sales by Country (2018-2029)
3.7.3 Latin America Chondroprotective Agent Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Chondroprotective Agent Market Facts & Figures by Country
3.8.1 Middle East and Africa Chondroprotective Agent Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Chondroprotective Agent Sales by Country (2018-2029)
3.8.3 Middle East and Africa Chondroprotective Agent Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Chondroprotective Agent Sales by Type (2018-2029)
4.1.1 Global Chondroprotective Agent Sales by Type (2018-2023)
4.1.2 Global Chondroprotective Agent Sales by Type (2024-2029)
4.1.3 Global Chondroprotective Agent Sales Market Share by Type (2018-2029)
4.2 Global Chondroprotective Agent Revenue by Type (2018-2029)
4.2.1 Global Chondroprotective Agent Revenue by Type (2018-2023)
4.2.2 Global Chondroprotective Agent Revenue by Type (2024-2029)
4.2.3 Global Chondroprotective Agent Revenue Market Share by Type (2018-2029)
4.3 Global Chondroprotective Agent Price by Type (2018-2029)
5 Segment by Application
5.1 Global Chondroprotective Agent Sales by Application (2018-2029)
5.1.1 Global Chondroprotective Agent Sales by Application (2018-2023)
5.1.2 Global Chondroprotective Agent Sales by Application (2024-2029)
5.1.3 Global Chondroprotective Agent Sales Market Share by Application (2018-2029)
5.2 Global Chondroprotective Agent Revenue by Application (2018-2029)
5.2.1 Global Chondroprotective Agent Revenue by Application (2018-2023)
5.2.2 Global Chondroprotective Agent Revenue by Application (2024-2029)
5.2.3 Global Chondroprotective Agent Revenue Market Share by Application (2018-2029)
5.3 Global Chondroprotective Agent Price by Application (2018-2029)
6 Key Companies Profiled
6.1 SANXIN
6.1.1 SANXIN Corporation Information
6.1.2 SANXIN Description and Business Overview
6.1.3 SANXIN Chondroprotective Agent Sales, Revenue and Gross Margin (2018-2023)
6.1.4 SANXIN Chondroprotective Agent Product Portfolio
6.1.5 SANXIN Recent Developments/Updates
6.2 WanTuMing Biological
6.2.1 WanTuMing Biological Corporation Information
6.2.2 WanTuMing Biological Description and Business Overview
6.2.3 WanTuMing Biological Chondroprotective Agent Sales, Revenue and Gross Margin (2018-2023)
6.2.4 WanTuMing Biological Chondroprotective Agent Product Portfolio
6.2.5 WanTuMing Biological Recent Developments/Updates
6.3 TSI Group
6.3.1 TSI Group Corporation Information
6.3.2 TSI Group Description and Business Overview
6.3.3 TSI Group Chondroprotective Agent Sales, Revenue and Gross Margin (2018-2023)
6.3.4 TSI Group Chondroprotective Agent Product Portfolio
6.3.5 TSI Group Recent Developments/Updates
6.4 Yantai Dongcheng
6.4.1 Yantai Dongcheng Corporation Information
6.4.2 Yantai Dongcheng Description and Business Overview
6.4.3 Yantai Dongcheng Chondroprotective Agent Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Yantai Dongcheng Chondroprotective Agent Product Portfolio
6.4.5 Yantai Dongcheng Recent Developments/Updates
6.5 Focus Chem
6.5.1 Focus Chem Corporation Information
6.5.2 Focus Chem Description and Business Overview
6.5.3 Focus Chem Chondroprotective Agent Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Focus Chem Chondroprotective Agent Product Portfolio
6.5.5 Focus Chem Recent Developments/Updates
6.6 YBCC
6.6.1 YBCC Corporation Information
6.6.2 YBCC Description and Business Overview
6.6.3 YBCC Chondroprotective Agent Sales, Revenue and Gross Margin (2018-2023)
6.6.4 YBCC Chondroprotective Agent Product Portfolio
6.6.5 YBCC Recent Developments/Updates
6.7 Runxin Biotechnology
6.6.1 Runxin Biotechnology Corporation Information
6.6.2 Runxin Biotechnology Description and Business Overview
6.6.3 Runxin Biotechnology Chondroprotective Agent Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Runxin Biotechnology Chondroprotective Agent Product Portfolio
6.7.5 Runxin Biotechnology Recent Developments/Updates
6.8 ISBA
6.8.1 ISBA Corporation Information
6.8.2 ISBA Description and Business Overview
6.8.3 ISBA Chondroprotective Agent Sales, Revenue and Gross Margin (2018-2023)
6.8.4 ISBA Chondroprotective Agent Product Portfolio
6.8.5 ISBA Recent Developments/Updates
6.9 Huiwen
6.9.1 Huiwen Corporation Information
6.9.2 Huiwen Description and Business Overview
6.9.3 Huiwen Chondroprotective Agent Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Huiwen Chondroprotective Agent Product Portfolio
6.9.5 Huiwen Recent Developments/Updates
6.10 QJBCHINA
6.10.1 QJBCHINA Corporation Information
6.10.2 QJBCHINA Description and Business Overview
6.10.3 QJBCHINA Chondroprotective Agent Sales, Revenue and Gross Margin (2018-2023)
6.10.4 QJBCHINA Chondroprotective Agent Product Portfolio
6.10.5 QJBCHINA Recent Developments/Updates
6.11 Meitek (Synutra International)
6.11.1 Meitek (Synutra International) Corporation Information
6.11.2 Meitek (Synutra International) Chondroprotective Agent Description and Business Overview
6.11.3 Meitek (Synutra International) Chondroprotective Agent Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Meitek (Synutra International) Chondroprotective Agent Product Portfolio
6.11.5 Meitek (Synutra International) Recent Developments/Updates
6.12 Hengjie Bio-Pharmaceuticals
6.12.1 Hengjie Bio-Pharmaceuticals Corporation Information
6.12.2 Hengjie Bio-Pharmaceuticals Chondroprotective Agent Description and Business Overview
6.12.3 Hengjie Bio-Pharmaceuticals Chondroprotective Agent Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Hengjie Bio-Pharmaceuticals Chondroprotective Agent Product Portfolio
6.12.5 Hengjie Bio-Pharmaceuticals Recent Developments/Updates
6.13 Nippon Zoki
6.13.1 Nippon Zoki Corporation Information
6.13.2 Nippon Zoki Chondroprotective Agent Description and Business Overview
6.13.3 Nippon Zoki Chondroprotective Agent Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Nippon Zoki Chondroprotective Agent Product Portfolio
6.13.5 Nippon Zoki Recent Developments/Updates
6.14 GGI
6.14.1 GGI Corporation Information
6.14.2 GGI Chondroprotective Agent Description and Business Overview
6.14.3 GGI Chondroprotective Agent Sales, Revenue and Gross Margin (2018-2023)
6.14.4 GGI Chondroprotective Agent Product Portfolio
6.14.5 GGI Recent Developments/Updates
6.15 Summit Nutritionals
6.15.1 Summit Nutritionals Corporation Information
6.15.2 Summit Nutritionals Chondroprotective Agent Description and Business Overview
6.15.3 Summit Nutritionals Chondroprotective Agent Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Summit Nutritionals Chondroprotective Agent Product Portfolio
6.15.5 Summit Nutritionals Recent Developments/Updates
6.16 Sioux Pharm
6.16.1 Sioux Pharm Corporation Information
6.16.2 Sioux Pharm Chondroprotective Agent Description and Business Overview
6.16.3 Sioux Pharm Chondroprotective Agent Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Sioux Pharm Chondroprotective Agent Product Portfolio
6.16.5 Sioux Pharm Recent Developments/Updates
6.17 Ruikangda Biochemical
6.17.1 Ruikangda Biochemical Corporation Information
6.17.2 Ruikangda Biochemical Chondroprotective Agent Description and Business Overview
6.17.3 Ruikangda Biochemical Chondroprotective Agent Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Ruikangda Biochemical Chondroprotective Agent Product Portfolio
6.17.5 Ruikangda Biochemical Recent Developments/Updates
6.18 Guanglong Biochem
6.18.1 Guanglong Biochem Corporation Information
6.18.2 Guanglong Biochem Chondroprotective Agent Description and Business Overview
6.18.3 Guanglong Biochem Chondroprotective Agent Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Guanglong Biochem Chondroprotective Agent Product Portfolio
6.18.5 Guanglong Biochem Recent Developments/Updates
6.19 Pacific Rainbow
6.19.1 Pacific Rainbow Corporation Information
6.19.2 Pacific Rainbow Chondroprotective Agent Description and Business Overview
6.19.3 Pacific Rainbow Chondroprotective Agent Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Pacific Rainbow Chondroprotective Agent Product Portfolio
6.19.5 Pacific Rainbow Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Chondroprotective Agent Industry Chain Analysis
7.2 Chondroprotective Agent Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Chondroprotective Agent Production Mode & Process
7.4 Chondroprotective Agent Sales and Marketing
7.4.1 Chondroprotective Agent Sales Channels
7.4.2 Chondroprotective Agent Distributors
7.5 Chondroprotective Agent Customers
8 Chondroprotective Agent Market Dynamics
8.1 Chondroprotective Agent Industry Trends
8.2 Chondroprotective Agent Market Drivers
8.3 Chondroprotective Agent Market Challenges
8.4 Chondroprotective Agent Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
